Sudeep Pharma IPO Allotment Status: Step by Step to check via Linkintime
Are you waiting for the Sudeep Pharma IPO allotment? Good news - the allotment will be out today i.e. 26th November 2025! Let's look at the latest Grey Market Premium (GMP), Allotment Chances and how you can check the IPO allotment status.
Latest Grey Market Premium (GMP)
The grey market premium shows how investors feel about the IPO before listing. Here's how Sudeep Pharma GMP has changed:
| Date | IPO Price | GMP | Expected Listing Price |
|---|---|---|---|
| November 26 (Today) | ₹593.00 | ₹87.00 | ₹680 (14.67%) |
Join us on Telegram: Click Here
Final Subscription in Sudeep Pharma:
| Category | Subscription |
|---|---|
| Qualified Institutional Buyers | 213.08x |
| Non-Institutional Investors | 116.72x |
| Small HNI | 80.33x |
| Big HNI | 134.91x |
| Retail Investors | 15.65x |
| Total | 93.71x |
Allotment Chances in Sudeep Pharma:
| Category | Allotment Chances |
|---|---|
| Small HNI | 1 out of 76 |
| Big HNI | 1 out of 27 |
| Retail Investors | 1 out of 13 |
How to Check Sudeep Pharma IPO Allotment Status
Sudeep Pharma IPO allotment status will be available on Wednesday, November 26, 2025. Here's how you can check:
Option 1: Via IPOwiz App
- Download the IPOwiz App from the Play Store.
- Add the PAN numbers you want to check in the PAN section.
- Go to the Allotted Section and select Sudeep Pharma IPO.
- View the allotment status for the saved PAN numbers.
Option 2: Via Linkintime Website
- Visit the Linkintime IPO Allotment Page.
- Select Sudeep Pharma IPO from the drop-down menu.
- Enter your PAN number, application number, or demat account details.
- Click Search to view your allotment status.
Option 3: Via BSE Website
- Go to the BSE Website.
- Choose Sudeep Pharma IPO from the list.
- Enter your PAN number, application number, or demat account details.
- Click Search to check your status.
Option 4: Via Demat Account
- Log in to your demat or trading account.
- Check if the allotted shares are credited. If yes, the shares will reflect in your account.
Option 5: Via Bank Account
- Log in to the bank account used for the IPO application.
- Check if the amount is debited. If debited, it means you’ve been allotted shares. If not, the amount will be refunded.
Sudeep Pharma IPO Key Dates
- IPO Open Date: November 21, 2025
- IPO Close Date: November 25, 2025
- Allotment Date: November 26, 2025
- Refund Date: November 27, 2025
- Demat Credit Date: November 27, 2025
- Listing Date: November 28, 2025
About Sudeep Pharma
Sudeep Pharma is a technology-led manufacturer of excipients and specialty mineral ingredients used globally in pharmaceutical, food, and nutrition industries. The company utilizes in-house technologies such as encapsulation, spray drying, and liposomal preparations to produce high-value mineral-based ingredients (calcium, iron, zinc, etc.). Sudeep Pharma is one of the largest producers of food-grade iron phosphate globally and is one of the few companies with a USFDA-approved facility for manufacturing mineral-based ingredients. It serves over 1,100 customers worldwide, including major names like Pfizer, Merck, Danone, Intas, and Mankind.
FAQs
1. When will the Sudeep Pharma IPO allotment be finalized?
Sudeep Pharma IPO allotment will be available on November 26, 2025.
2. How to check Sudeep Pharma IPO allotment status?
You can check the allotment via IPOwiz App, Linkintime website, BSE, or your demat account.
3. What is the expected listing price of Sudeep Pharma IPO?
Based on ₹87.00 GMP, the expected listing price is ₹680 (14.67% above IPO price).
4. What are the allotment chances for retail investors?
Retail investors have 1 out of 13 chance.
5. When will shares be credited to demat accounts?
Shares will be credited by November 27, 2025 for successful allotments.
6. When is Sudeep Pharma IPO listing date?
The shares will list on BSE/NSE on November 28, 2025.
7. Can I sell shares on listing day?
Yes, you can sell allotted shares when trading begins on November 28.
8. Is Sudeep Pharma IPO good for long-term?
GMP suggests good listing gains, but analyze fundamentals post-listing for long-term.
For further queries, contact the IPO registrar, Linkintime.